EMA publishes 2025 annual report of Pharmacovigilance Inspectors Working Group
The EU regulator has issued the yearly report of the group of inspectors who work on pharmacovigilance inspection matters, covering the 2025 calendar year.
The European Medicines Agency has published the annual report of the Pharmacovigilance Inspectors Working Group for 2025. The item is dated 9 October 2026.
The material available to VigiEye consists only of the document title and a truncated summary. It does not include the report's text, so inspection figures, findings, priorities and any recommendations cannot be reported here.
As general context, the working group brings together inspectors from EU and EEA authorities to coordinate pharmacovigilance inspection activity. Its annual report is the usual place where the group sets out what it did over the year.
What it means for your team
- The full report should be read directly on the EMA website, as no details of its content were available for this article.
- PV and quality teams preparing for inspections may want to check whether the report describes inspection trends or areas of focus for 2025.
- Teams should avoid drawing conclusions about inspection outcomes until they have reviewed the published document.
Article written by VigiEye from the official source (EMA). AI-assisted; check the source before acting.